Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Diabetes. 2019 Dec 27;69(3):477–483. doi: 10.2337/db19-1029

Table 1. Patients’ clinical features.

Case # 1 2 3 4 5
Mutation c.131G>A
p.(Gly44Asp)
c.131G>T
p.(Gly44Val)
c.230G>A
p.(Ser77Asn)
c.101T>G
p.(Leu34Trp)
c.915_916del,
p.(*306Thrext*12)
De novo Yes Yes Yes Yes Yes
Sex Male Male Female Male Male
Current age (years) 5 5 Deceased 13 18
Country Vietnam Jordan Chile England Israel
Birth Weight (g) 2600 3000 2986 2920 3600
Gestation (weeks) 39 N/A 40 40 42
Birth weight centile (SDS) 4th (-1.74) N/A 18th (-0.90) 7th (-1.44) 20th (-0.84)
Diabetes features
Age at onset (weeks) 9 4 17 56 21
Insulin treatment from diagnosis, 0.46U/kg/day (at 2 months) from diagnosis, 0.8U/kg/day from diagnosis, 1.0U/kg/day from diagnosis, 0.7U/kg/day from diagnosis, 0.75U/kg/day
Hepatic features
Age at first episode of liver dysfunction 38 months None reported 16 months 18 months 5 months
Outcome of first episode Resolved N/A Decease Resolved Resolved
Recurrent episodes No N/A N/A Yes, 8 episodes Yes, 2 episodes
Age at last episode of liver dysfunction N/A N/A N/A 5.5 years 5.5 months
Other features
Neurological features None None None Mild learning disability Attention deficit disorder
Additional Comments Anaemia Died at 16 months following respiratory infection and acute liver failure Renal failure at 14 years